Granulomatosis with Polyangiitis

Granulomatosis with Polyangiitis (GPA) is a systemic, necrotizing granulomatous vasculitis primarily affecting small-to-medium-sized blood vessels. It is characterized by the triad of upper and lower respiratory tract involvement and glomerulonephritis.

The exact cause remains idiopathic. It is considered an autoimmune process triggered by an interplay between genetic predisposition (e.g., HLA-DPB10401) and environmental factors such as silica exposure, infectious agents, and chronic nasal carriage of Staphylococcus aureus*.

GPA is mediated by Anti-Neutrophil Cytoplasmic Antibodies (ANCAs), specifically anti-PR3 (Proteinase 3). These antibodies activate neutrophils, causing them to adhere to the vascular endothelium, release reactive oxygen species and lytic enzymes, leading to necrotizing inflammation, granuloma formation, and secondary tissue ischemia.

The annual incidence is approximately 5–10 per million. It affects all age groups but peaks between 40 and 65 years. There is no significant gender predilection.

Genetic susceptibility (HLA markers), environmental toxin exposure (silica, welding fumes), and chronic S. aureus colonization.

A. Early Symptoms: Persistent rhinorrhea, nasal crusting, sinusitis, fatigue, arthralgia.
B. Common Symptoms: Cough, hemoptysis, dyspnea, hematuria, weight loss.
C. Advanced Symptoms: Saddle-nose deformity, renal failure, peripheral neuropathy (mononeuritis multiplex), skin ulcers.
D. Emergency Symptoms: Alveolar hemorrhage (respiratory distress), rapid glomerulonephritis (oliguria), severe ocular proptosis.

Tachypnea, nasal septal perforation, wheezing, rales, hypertension (renal involvement), purpura/livedo reticularis, and decreased visual acuity.

A. Clinical Assessment: Symptom chronology and physical exam.
B. Laboratory Testing: ANCA titers (c-ANCA/PR3).
C. Imaging Studies: High-resolution CT (HRCT) of the chest.
D. Functional Tests: Pulmonary Function Tests (PFTs).
E. Biopsy Findings: Necrotizing granulomatous inflammation with vasculitis.
F. Genetic Testing: Not standardly utilized.
G. Differential Diagnosis: Eosinophilic granulomatosis with polyangiitis (EGPA), Goodpasture syndrome, sarcoidosis.

Test Name: Anti-PR3 (c-ANCA)
Type: Blood Test
Purpose: Specific marker for GPA
Expected Findings: Positive
Interpretation: Highly specific; correlates with disease activity.

Chest HRCT: Identifies pulmonary nodules, infiltrates, or cavitation. Vital for assessing pulmonary burden.

Microscopic Polyangiitis (no granulomas), Sarcoidosis (non-necrotizing), Tuberculosis (rule out via sputum/biopsy).

End-stage renal disease (ESRD), chronic airway stenosis, hearing loss, therapy-related malignancy (bladder cancer from Cyclophosphamide).

A. Lifestyle Modifications: Smoking cessation, infection avoidance.
B. Preventive Measures: Vaccination, prophylactic antibiotics for opportunistic infections.
C. Medical Treatment: Induction with Rituximab or Cyclophosphamide; maintenance with Azathioprine or Methotrexate. Glucocorticoids are used for acute control.
D. Surgical Treatment: Endoscopic sinus surgery, tracheal stenting.
E. Interventional Procedures: Plasmapheresis in severe pulmonary hemorrhage.
F. Rehabilitation: Physical therapy.
G. Emergency Management: Pulse dose IV steroids, respiratory support.

Historically fatal; currently, 80% achieve remission with aggressive immunosuppression, though relapse is common (up to 50%).

Secondary prevention focuses on early detection of relapse via serial ANCA monitoring and urinalysis.

The following homeopathic remedies have been historically indicated for symptoms associated with Granulomatosis with Polyangiitis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Granulomatosis with Polyangiitis.